BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 28774669)

  • 1. Neurodevelopmental disorders in children with macrocephaly: A prevalence study and PTEN gene analysis.
    Kurata H; Shirai K; Saito Y; Okazaki T; Ohno K; Oguri M; Adachi K; Nanba E; Maegaki Y
    Brain Dev; 2018 Jan; 40(1):36-41. PubMed ID: 28774669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly.
    Varga EA; Pastore M; Prior T; Herman GE; McBride KL
    Genet Med; 2009 Feb; 11(2):111-7. PubMed ID: 19265751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening.
    Marchese M; Conti V; Valvo G; Moro F; Muratori F; Tancredi R; Santorelli FM; Guerrini R; Sicca F
    BMC Med Genet; 2014 Feb; 15():26. PubMed ID: 24580998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly.
    Orrico A; Galli L; Buoni S; Orsi A; Vonella G; Sorrentino V
    Clin Genet; 2009 Feb; 75(2):195-8. PubMed ID: 18759867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay.
    Lynch NE; Lynch SA; McMenamin J; Webb D
    Arch Dis Child; 2009 Jul; 94(7):553-4. PubMed ID: 19321504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical screening and PTEN mutation analysis in individuals with autism spectrum disorders and macrocephaly.
    Hobert JA; Embacher R; Mester JL; Frazier TW; Eng C
    Eur J Hum Genet; 2014 Feb; 22(2):273-6. PubMed ID: 23695273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a PTEN mutation with reduced protein stability, phosphatase activity, and nuclear localization in Hong Kong patients with autistic features, neurodevelopmental delays, and macrocephaly.
    Wong CW; Or PMY; Wang Y; Li L; Li J; Yan M; Cao Y; Luk HM; Tong TMF; Leslie NR; Lo IF; Choy KW; Chan AML
    Autism Res; 2018 Aug; 11(8):1098-1109. PubMed ID: 29608813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience.
    Ciaccio C; Saletti V; D'Arrigo S; Esposito S; Alfei E; Moroni I; Tonduti D; Chiapparini L; Pantaleoni C; Milani D
    Eur J Med Genet; 2019 Dec; 62(12):103596. PubMed ID: 30528446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical/molecular characteristics of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly.
    Kaymakcalan H; Kaya İ; Cevher Binici N; Nikerel E; Özbaran B; Görkem Aksoy M; Erbilgin S; Özyurt G; Jahan N; Çelik D; Yararbaş K; Yalçınkaya L; Köse S; Durak S; Ercan-Sencicek AG
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1739. PubMed ID: 34268892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly.
    Buxbaum JD; Cai G; Chaste P; Nygren G; Goldsmith J; Reichert J; Anckarsäter H; Rastam M; Smith CJ; Silverman JM; Hollander E; Leboyer M; Gillberg C; Verloes A; Betancur C
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):484-91. PubMed ID: 17427195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.
    Yeung KS; Tso WWY; Ip JJK; Mak CCY; Leung GKC; Tsang MHY; Ying D; Pei SLC; Lee SL; Yang W; Chung BH
    Mol Autism; 2017; 8():66. PubMed ID: 29296277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
    Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
    Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly.
    McBride KL; Varga EA; Pastore MT; Prior TW; Manickam K; Atkin JF; Herman GE
    Autism Res; 2010 Jun; 3(3):137-41. PubMed ID: 20533527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics and Genotype-Phenotype Correlation in Children with KMT2E Gene-Related Neurodevelopmental Disorders: Report of Two New Cases and Review of Published Literature.
    Sharawat IK; Panda PK; Dawman L
    Neuropediatrics; 2021 Apr; 52(2):98-104. PubMed ID: 33111303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.
    Butler MG; Dasouki MJ; Zhou XP; Talebizadeh Z; Brown M; Takahashi TN; Miles JH; Wang CH; Stratton R; Pilarski R; Eng C
    J Med Genet; 2005 Apr; 42(4):318-21. PubMed ID: 15805158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8.
    Yasin H; Gibson WT; Langlois S; Stowe RM; Tsang ES; Lee L; Poon J; Tran G; Tyson C; Wong CK; Marra MA; Friedman JM; Zahir FR
    J Hum Genet; 2019 Apr; 64(4):271-280. PubMed ID: 30670789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive facies, macrocephaly, and developmental delay are signs of a PTEN mutation in childhood.
    Kato K; Mizuno S; Inaba M; Fukumura S; Kurahashi N; Maruyama K; Ieda D; Ohashi K; Hori I; Negishi Y; Hattori A; Saitoh S
    Brain Dev; 2018 Sep; 40(8):678-684. PubMed ID: 29752200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrocephaly as a clinical indicator of genetic subtypes in autism.
    Klein S; Sharifi-Hannauer P; Martinez-Agosto JA
    Autism Res; 2013 Feb; 6(1):51-6. PubMed ID: 23361946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCAM2 deletion in a boy with macrocephaly and autism: Cause, association or predisposition?
    Scholz C; Steinemann D; Mälzer M; Roy M; Arslan-Kirchner M; Illig T; Schmidtke J; Stuhrmann M
    Eur J Med Genet; 2016 Oct; 59(10):493-8. PubMed ID: 27596683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
    Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
    Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.